genomics

SNP chip data often reported by consumer genomics companies should not be considered for clinical decisions without additional validation, warn researchers.

The funding was led by ETF and an investor consortium from across AI, science and analytics.

Dr. Liz Kwo breaks down the data and technology-enabled healthcare tools being adopted by next-generation payers and providers.

Flare Capital Partners offers an overview of sequencing options, opportunities for integration into clinical workflow and the companies making that happen.

The blockchain-enabled startup's new pilot will rely on its database of sequenced genomes. 

Mendelian, a UK healthtech startup, has received a £500,000 grant from Innovate UK to build platforms that will help GPs to identify NHS patients with potentially rare or hard-to-diagnose conditions and diseases more quickly.

The company claims it is the first to work with the SEC to figure out how consumers could exchange health data for equity.  

Kamal Obbad, Co-founder and CEO of Nebula Genomics, is working to help consumers understand consent and the risks to consider before giving someone access to their data based on a blockchain model.  Nebula Genomics was the winner of the 2018 Health 2.0 Launch! contest.

In the last few years consumer genomics has grown in both its offerings and legitimacy.

DNA, health records, and blood test results are not only intimately personal, they are also a valuable asset to researchers.